Skip to content

Palatability Testing of a New Paediatric Formulation of Valacyclovir

Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01682109
Acronym
VALID-0
Enrollment
41
Registered
2012-09-10
Start date
2012-09-30
Completion date
2016-03-31
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Simplex Virus Infection, Varicella Zoster Virus Infection

Keywords

prophylaxis, herpes zoster, herpes simplex, valacyclovir, palatability, paediatric

Brief summary

Palatability testing of a new paediatric formulation of valacyclovir in children 4-12 years of age and at least one of their parents. Children will be included, who received (val)acyclovir prophylaxis in the past, or will probably need it in the future i.e. children with primary immune deficiency or cancer.

Interventions

DRUGValacyclovir

Sponsors

ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject is at least 4 years of age. * Subject weighs at least 15kg. * Subject is capable of performing the taste assessment, according to the investigator's judgement. * The child and parent(s) are willing to participate in the taste assessment. * Signed informed consent by the legal guardian for participation of the child and if the parent also wants to participate: signed informed consent for their own participation, prior to start of the study.

Exclusion criteria

* Documented history of sensitivity/idiosyncrasy to medicinal products or excipients. * Presence of any condition that influences taste sensation (such as upper respiratory infection, febrile illness within 3 days before the first dose, mucositis or use of medication that influences taste perception, as described in the label information).

Design outcomes

Primary

MeasureTime frameDescription
Selection of oral solution with best tasteDay 1Patients (children) will assess the taste of 3 different oral solutions. A questionnaire has to be completed to order the palatability of the three formulations.

Secondary

MeasureTime frameDescription
Taste assessmentDay 1Children will score the taste of 3 different oral valacyclovir solutions. A 100 mm facial hedonic scale will be employed to indicate the palatability of each formulation.
Predictability of palatability preference of the child by parents.Day 1To determine whether parents can predict the palatability preference of their child.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026